Skip to main content
. 2015 Jul 30;34(Suppl 1):9–15. doi: 10.1007/s10067-015-3012-0

Table 1.

Comparison of costs in patients with rheumatoid arthritis in Latin America

Country/year Total direct costs US$ Drug costs (%) Medical costs (%) Other costs (%) Synthetic DMARDs Biologic agents
Mexico 2005 (12) 1735 25.76 51.33 22.9 Yes Do not
Brazil 2008 (13) 14,185 90.8 6.8 2.4 Yes Yes
Colombia 2009 (14) 1,689–23,441a 86 14 Yes Yes

aDepending on the rate of activity of the AR